WJ-39

Overview

WJ-39 is an orally active aldose reductase ( AR ) inhibitor. WJ-39 improves tubular damage in diabetic nephropathy rats by activating PINK1/Parkin signaling, promoting mitophagy , and attenuating apoptosis .

Application

Products | Products > Disease Areas > Metabolic or Endocrine Disease | Products > Disease Areas > Digestive System Disease | Products > Disease Areas > Digestive System Inflammation | Products > Disease Areas > Glucose Metabolism | Products > Disease Areas > Inflammation or Immune System Disease | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Signaling Pathways > Apoptosis | Products > Signaling Pathways > Autophagy | Products > Research Areas > Metabolic Disease | Products > Signaling Pathways > Aldose Reductase | Products > Signaling Pathways > Mitochondrial Metabolism | Products > Signaling Pathways > Apoptosis | Products > Signaling Pathways > Mitophagy

Product Information

• Catalog No.: HY-162325
• CAS No.: 3009908-95-3
• Molecular Formula: C19H14Cl2KNO4
• Molecular Weight: 430.32
• Purity: 99.60%
• Storage: 4°C, protect from light * In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)
• Availability: In-stock

Source

Original product source